Members of the Fanconi anemia (FA) protein family are involved in repair of genetic damage caused by DNA cross-linkers. It is not clear whether the FA proteins function in oxidative DNA damage and oncogenic stress response. Here, we report that deficiency in the Fanca gene in mice elicits a p53-dependent growth arrest and DNA damage response to oxidative DNA damage and oncogenic stress. Using a Fanca À/À Trp53
Introduction
Research on Fanconi anemia (FA) has recently generated great interest because the disease serves as an excellent model for hematopoietic failure and leukemic evolution. FA is a genetic disorder associated with bone marrow (BM) failure and cancers, particularly leukemia (1) (2) (3) . FA is genetically heterogeneous, with 13 complementation groups identified thus far. The genes encoding the groups A (FANCA), B (FANCB), C (FANCC), D1 (FANCD1/BRCA2), D2 (FANCD2), E (FANCE), F (FANCF), G (FANCG), -I (FANCI/KIAA1794), J (FANCJ/BRIP1), L (FANCL), M (FANCM), and N (FANCN/PALB2) have been cloned (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . The biological function of FA proteins has been the subject of intense investigation in recent years.
Because cells deficient for FA genes are hypersensitive to DNA cross-linking agents, such as mitomycin C and diepoxybutane, it has been proposed that the FA proteins may be involved in the sensing and/or repair of DNA interstrand cross-links. This model is supported by evidence that shows that an intact FA nuclear complex is required for biochemical modification in the form of monoubiquitination of FANCD2 and FANCI as mutations in any one of the FA proteins that disrupt the complex prevent the activation of FANCD2 and FANCI, leading to cross-linker hypersensitivity and the characteristic broken and radial chromosome formation in FA cells (3, 18) . The common damage to DNA in vivo is oxidative stress, and ample evidence has suggested that FA cells are in an in vivo prooxidant state (19) and that the FA proteins may play important roles in cellular responses to oxidative stress. For example, the FANCC protein has been found to interact with NADPH cytochrome P450 reductase and glutathione S-transferase P1-1 (20, 21) , two enzymes involved in either triggering or detoxifying reactive intermediates, including reactive oxygen species. In addition, mice with combined deficiencies of the antioxidative enzyme, Cu/Zn superoxide dismutase, and the Fancc genes showed a defective hematopoiesis (22) . Another FA protein, FANCG, interacts with cytochrome P450 2E1 (23) and mitochondrial peroxiredoxin-3 (24) , suggesting a possible role of FANCG in protection against oxidative DNA damage. Recently, Saadatzadeh and colleagues (25) showed that oxidant hypersensitivity of Fancc À/À cells was due to an altered redox regulation and hyperactivation of the serine-threonine kinase apoptosis signalregulating kinase 1, an important kinase involved in oxidantinduced apoptosis. Moreover, oxidative stress induces complex formation by two major FA proteins, FANCA and FANCG (26) . These observations corroborate a critical role for oxidative stress in FA phenotype and disease progression. Cells from patients with FA gene mutations have high predisposition to leukemia and other cancers. However, little is known about whether these mutant cells have high susceptibility to oncogenic transformation. In response to oncogenic activation, normal cells induce genetically encoded programs that prevent deregulated proliferation and, thus, protect multicellular organisms from cancer progression. Two such programs induced by oncogenic activation are apoptosis and senescence, which are normally triggered by DNA damage or other stresses. Studies have shown that overexpression of antiapoptotic proteins, such as Bcl-2, or deletion of apoptosis-associated and senescence-associated proteins, such as p53, accelerates oncogene-induced tumorigenesis (27, 28) . The theory that has risen from these findings is that oncogene-driven proliferation must be associated with inhibition of apoptosis and senescence to allow malignant outgrowth.
The tumor suppressor p53 is a key transcription factor that activates vital damage containment procedures to restrict aberrant cell growth in response to DNA damage, oncogene activation, and loss of normal cell contacts (29, 30) . p53 restricts cellular growth by inducing senescence, cell cycle arrest, or apoptosis (31) . Thus, p53 plays a major role in the prevention of cancer. Consistent with this, emerging evidence suggests that p53 deficiency may increase cancer development in patients with FA and FA mice. For example, studies have indicated a higher proportion of human papillomavirus-positive squamous cell carcinomas in patients with FA than in healthy controls, indicating that loss of functional p53 facilitates tumor development (32, 33) . Mice deficient for Fancd1 or Fancd2 have been shown to have accelerated tumor development in Trp53-deficient background (34, 35) . In addition, Fancc deficiency accelerates the development of certain blood and solid tumors in mice heterozygous at Trp53 (36) . Moreover, these studies found that the FA proteins and p53 cooperate in apoptosis and cell cycle checkpoint control after DNA damage (35, 37, 38) . In this study, we show that p53 is engaged differentially in response to oxidative and oncogenic stresses in FA cells in vitro and in vivo.
Materials and Methods
Mice. Wild-type (WT), Fanca À/À mice and double knockout mice (p53 À/À ; Fanca À/À ) were generated by interbreeding the heterozygous Fanca +/À and p53 +/À mice. The genetic background of the mice was C57BL/6 mice, which were used at f6 to 10 wk of age. All experimental procedures conducted in this study were approved by the institutional animal care and use committee of Cincinnati Children's Hospital Medical Center.
Isolation of BM lineage-depleted cells and differentiation assay. The femora and tibiae were harvested from the mice immediately after their sacrifice with CO 2 . BM cells were flushed from bones into Iscove's modified Dulbecco's medium (IMDM; Invitrogen) containing 10% FCS, using a 21-guage needle and syringe. Low-density BM mononuclear cells (BMMNC) were separated by Ficoll Hypaque density gradient (Sigma) and washed with IMDM. BMMNC were depleted of lineage-committed cells using a lineage cell depletion kit (Miltenyi Biotec, Inc.) in accordance with the manufacturer's instruction. For myeloid and lymphoid differentiation, BM LinÀ cells were cultured with various cytokine combinations known to support myeloid [100 ng/mL stem cell factor (SCF), 10 ng/mL granulocytemonocyte colony-stimulating factor (GM-CSF)] or lymphoid [100 ng/mL SCF, 10 ng/mL each of interleukin-3 (IL-3) and IL-7] differentiation. After 5 d, cells were stained with antibodies against myeloid markers Gr-1 and Mac-1 or lymphoid markers B220 and CD3e, followed by flow cytometric analysis using a FACSCalibur (Becton Dickinson).
Mouse embryonic fibroblast isolation and culture. Mouse embryonic fibroblasts (MEF) were prepared from day 13.5 embryo derived from crosses of p53 +/À with Fanca +/À mice. The head and the red organs were removed, and the torso was minced and dispersed with 0.25% trypsin-EDTA by using 20-gauge needle. Single-cell suspension obtained was cultured in DMEM containing 10% fetal bovine serum, glutamine, MEM nonessential amino acid, penicillin/streptomycin, and gentamicin under 5% CO 2 for 3 d until the genotypes were confirmed. Cells were then trypsinized and expanded for experimental use. MEFs were further maintained on the basis of 3T3 protocol.
Construction of retroviral expression vectors. The full-length human FANCA cDNA was subcloned into the NotI site of retroviral vector MIEG3 to create MIEG3-FANCA. The WT mouse p53 (mp53wt), a temperaturesensitive mutant p53 (tsp53 V143A ), and H-ras V12 cloned in MIEG3 were kindly provided by Dr. Yi Zheng (Cincinnati Children's Medical Center). The plasmids (10 Ag each) were used to produce retroviral supernatant.
Retroviral-mediated gene transfer. Helper virus-free Phoenix packaging cells (kindly provided by Dr. Gary Nolan, Stanford University) were plated at the density of 3 Â 10 6 in 10-cm tissue culture dish and incubated for 24 h. Cells were then transfected by calcium phosphate precipitation with 10 Ag of retroviral plasmids (15 h at 37jC). Retroviral supernatant was collected at different time points (24, 36 , and 48 h), respectively. After transfection, the virus-containing medium was filtered (0.45 Am filter, Millipore) and aliquoted at À80jC. WT, Fanca Colony and cell proliferation assay. Low-density BMMNCs were plated in a 35-mm tissue culture dish in 4 mL of semisolid medium containing 3 mL of MethoCult M 3134 (Stem Cell Technologies) and the following growth factors: 100 ng/mL SCF, 10 ng/mL IL-3, 100 ng/mL GM-CSF, and 4 units/mL erythropoietin (Peprotech). On day 10 after plating, erythroid and myeloid colonies were enumerated. Hematopoietic clonal growth results were expressed as means (of triplicate plates) F SD of three experiments. For proliferation, cells were cultured for 24 h in normal growth medium supplemented with 10 Amol/L BrdUrd (Sigma), harvested, and fixed in 70% ethanol. BrdUrd-labeled cells fixed in 70% ethanol were treated with 2 N HCl (20 min at room temperature), followed by addition of two volumes of 0.1 mol/L sodium borate (pH 8.5). The cells were incubated with an anti-BrdUrd mouse monoclonal antibody, washed, and incubated with FITC-conjugated antimouse antibody. Cells were counterstained overnight with 5 Ag/mL of propidium iodide containing 40 Ag/mL of RNase. The stained cells were analyzed by flow cytometry.
Apoptosis assay and cell cycle analysis. Cells were stained with Annexin V and 7AAD using BD ApoAlert Annexin V kit (BD Pharmingen) in accordance with the manufacturer's instruction. Apoptosis was analyzed by quantification of Annexin V-positive cell population by flow cytometry. For cell cycle analysis, cells were fixed with 0.25% formaldehyde in PBS and permeabilized with 0.3% Nonidet P-40. Cells were then stained with propidium iodide containing 1 mg/mL RNase A, followed by fluorescenceactivated cell sorting (FACS) analysis for G 0 -G 1 , S, and G 2 -M populations using a FACS caliber.
Immunocytochemistry. Cells were plated on 18-mm diameter glass coverslips and allowed to recover for 24 h before treatment with H 2 O 2 . Treated cells were fixed with 4% formaldehyde in PBS for 20 min at room temperature. Cells were then washed with PBS and permeabilized with 0.2% Triton X-100 in 3% bovine serum albumin (BSA)/PBS for 10 min at room temperature. The cells were then washed with PBS and blocked with 10% BSA/PBS solution for 1 h at room temperature. Cells were then incubated with primary antibodies against p53, p53 Plates were incubated at 37jC or 32jC. Every third day, cells were trypsinized and counted with a hemacytometer, and the same number of cells was replated in six-well tissue culture plates. Senescence-associated B-galactosidase. Senescence-associated h-galactosidase (SA-h-gal) activity was determined using a SA-h-gal staining kit (Cell Signaling Technology) according to the manufacturer's instructions. Briefly, cells were washed once with PBS and fixed with 0.5% glutaraldehyde. Cells were further washed with PBS and stained with X-gal solution (1 mg/mL X-gal) overnight at 37jC. The percentage of positive-stained cells was quantified under a phase-contrast microscope.
Immunohistochemistry. Spleen, thymus, and bone were fixed with formalin and embedded in paraffin for sectioning. After deparaffinization and hydration, sections were blocked with 10% serum in PBS for 30 min and then incubated with 1:50 diluted anti-p53 or 1:50 diluted anti-p21 WAF1 (all from Santa Cruz Technologies) primary antibodies overnight at 4jC, followed by three washing with PBS at 5-min interval. Detection of p53 and p21 WAF1 staining was performed using the biotin peroxidase complex method (Vectastain ABC kits, Vector Laboratories). Color was developed with diaminobenzidie tetrahydrochloride, and nuclei were stained with hematoxylin.
Preparation of cell extracts and immunoblotting. To prepare cell protein, single-cell suspension was prepared from BMMNCs, spleenocytes, or trypsinized MEFs, washed with ice-cold PBS, and resuspended in ice-cold lysis buffer containing 50 mmol/L Tris-HCL (pH 7.4), 0.1% NP40, and 1mol/L NaCl supplemented with protease and phosphatase inhibitors [10 Ag/mL aprotinin, 25 Ag/mL leupeptin, 10 Ag/mL pepstatin A, 2 mmol/L phenylmethylsulfonyl fluoride, 0.1mol/L NaP 2 O 4 , 25 mmol/L NaF, and 2 mmol/L sodium orthovandate] for 30 min on ice. Cell debris was removed from the lysates by centrifuging them at 14,000 rpm for 30 min. Protein concentration was quantified by using Bio-Rad reagent. Cell lysates (100 Ag) were resolved on (12%) SDS-PAGE and transferred onto nitrocellulose membranes. Immunoblots were then incubated with primary antibodies specific for p53, p53 Ser20 , and p21 WAF1 (Santa Cruz Biotechnologies), g H 2 AX (Upstate Biotechnology), and phosphorylated pRB, phosphorylated p38, phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2), and the pan kinases p38 and ERK1/2 (all from Cell Signaling) or h-actin (Sigma) for 12 to 16 h at 4jC. Signals were revealed after incubation with antimouse or antirabbit secondary antibodies.
Statistics. Data were analyzed statistically using a Student's t test. The level of the statistical significance stated in the text was based on the P values. P < 0.05 was considered statistically significant. (Fig. 1C) . Together, these results indicate that loss of FA function results in cellular hypersensitivity to oxidants. Oxidative stress induces premature senescence by activating several major signaling pathways, including the p16 INK4A /pRB and ADP ribosylation factor/p53 pathways (39) . Oncogene Ras has also been shown to induce cell growth arrest after oxidative injury by activating the mitogen-activated protein kinase (MAPK) pathway (40) . We, therefore, examined the expression and activities of proteins and enzymes in the Ras, p53, and pRB pathways. We did not find significantly elevated Ha-Ras expression or the downstream activation of the MAPK kinases ERK and p38 in senescent Fanca À/À cells treated with 10 Amol/L H 2 O 2 ( Fig. 1D, left Fig. 4 , p53 activation (in the form of p53 Ser20 ) was short-lived in both marrow (Fig. 4A) and spleen (Fig. 4B) The observation that H 2 O 2 -induced expression of the DSB marker gH2AX seemed to be more pronounced and sustained in the BM than in spleen raised the question as to whether there was a lineage-specific effect on oxidative DNA damage in Fanca À/À mice. To address this, we determined H 2 O 2 -induced DSBs in lymphoid and myeloid cells (Fig. 4C) (Fig. 4D) . Ser20 and gH 2 AX. C, BM LinÀ cells from WT and Fanca À/À littermates were cultured with cytokine combinations known to support myeloid (SCF, 100 ng/mL; GM-CSF, 10 ng/mL) or lymphoid (SCF, 100 ng/mL; IL-3, 10 ng/mL; IL-7, 10 ng/mL) differentiation for 5 d. Cells were then stained with antibodies for lineage-specific markers (myeloid, Gr-1 and Mac-1; lymphoid, B220 and CD3e) followed by flow cytometry. Horizontal axes, fluorescence intensity; vertical axes, relative cell number; solid line, staining with test antibody; dashed line, staining with an isotype-matched control antibody. D, H 2 O 2 -induced DNA DSBs in Fanca À/À BM myeloid and lymphoid cells. Fanca À/À BM myeloid and lymphoid cells described in C were treated with H 2 O 2 (100 mmol/L) for 0, 4, or 8 h, and protein extracts were prepared and analyzed by immunoblotting with anti-gH2AX and antiactin antibodies.
Cancer Research
Cancer Res 2008; 68: (23 V143A -expressing cells cultured at 32jC (Fig. 5A) . A prolonged time course analysis of cell growth indicated that, at nonpermissive temperature (37jC), loss of p53 function almost completely abolished growth response to H 2 O 2 in cells with or without the Fanca protein (Fig. 5B) , suggesting that H 2 O 2 -induced damage response requires a functional p53. Indeed, when the function of p53 was restored at 32jC, H 2 O 2 -induced growth inhibition was clearly evident in both Fanca +/+ and Fanca À/À cells (Fig. 5C ). However, we observed differential responses to H 2 O 2 -induced stress in cells with different Fanca status. In Fanca +/+ cells, the p53 response to oxidative stress seemed to be relatively short (3-6 days) after the insult; whereas Fanca À/À cells underwent prolonged growth inhibition (Fig. 5C) . Interestingly, TUNEL assay indicated that p53 deficiency increased H 2 O 2 -induced apoptosis in Fanca À/À cells, which could be inhibited by functional tsp53 V143A (Fig. 5D) . Thus, although p53 caused prolonged proliferative suppression in Fanca À/À cells, a functional p53 seemed to be required for the survival of the mutant cells under oxidative stress. We next used the same cell system to explore the requirement for p53 function in response to oncogenic stress, specifically activated ras, which is a well-studied p53-antagonizing oncogene (44) . We infected tsp53 V143A -expressing Fanca +/+ ;Trp53 À/À and Fanca À/À ;Trp53 À/À MEFs with an H-Ras V12 retrovirus and monitored cell proliferation at 32jC or 37jC for a period of 15 days. Growth kinetics showed that at 37jC, wherein p53 was inactivated, all cell lines proliferated well regardless of the Fanca genotype (Fig. 6A) . When the cells were cultured at 32jC, wherein p53 was functional, Fanca +/+ cells exhibited persistent response to activated ras-induced growth arrest (Fig. 6A) . Interestingly, Fanca À/À cells initially responded to activated ras-triggered growth arrest and then started to proliferate like p53-null cells after day 6. These arrested cells expressed SA-h-gal and seemed morphologically senescent (Fig. 6B) .
The interesting observation that Fanca-deficient cells failed to respond to ras-induced growth arrest after 6 days of culture at permissive temperature (32jC) suggested that Fanca À/À cells might have lost their ability to engage p53 during constitutive ras activation. To test this hypothesis, we cultured H-Ras V12-transduced tsp53 V143A -expressing cells at 37jC for either 3 or 12 days and then restored p53 function by shifting the cultures to 32jC. Cell proliferation and induction of p21 WAF1 were analyzed by BrdUrd incorporation and Western blot, respectively. Both cell lines shifting to 32jC at day 3 underwent approximately same level of growth arrest with few cells in the S-phase population (Fig. 6C) , which was accompanied by strong induction of p21 WAF1 (Fig. 6D ). Whereas p53 restoration at day 12 could still triggered immediate growth arrest in Fanca +/+ ;Trp53 À/À cells; Fanca À/À ;Trp53 À/À cells showed lack of activated ras-induced growth arrest and p21 WAF1 expression ( Fig. 6C and D) . Therefore, loss of Fanca impairs p53 function during prolonged ras activation.
Discussion
Cellular stresses, most significantly oxidative DNA damage and oncogene insults, have been shown to activate p53 (45) . Given that p53 activation can lead to cell growth arrest or apoptosis, cancer cells, in particular, must have developed strategies to regulate p53 activity. In addition to the p53-negative regulator Mdm2, several p53-interacting proteins have been shown to regulate p53 activity. The interaction of p53 with other cellular proteins is known to influence the activity of the tumor suppressor (46) . Our finding that the Fanca protein coordinates with p53 to regulate oxidative and oncogenic stress responses supports the notion that a fine control of p53 activity is fundamentally important for cellular homeostasis and cancer prevention.
Patients with FA have an increased susceptibility to cancer, and cells from FA patients are deficient in repair of DNA damage induced by certain genotoxic agents. This suggests that the FA proteins may interplay with other tumor suppressor pathways that are involved in DNA damage repair and oncogenic signaling. Encouraged by recent reports that p53 deficiency increases cancer development in patients with FA and FA knockout mice (32-36), we formally tested the hypothesis that the FA proteins may functionally interact with the p53-activating signals in response to oxidative and oncogenic stresses. Our results suggest that the major FA protein, Fanca, may coordinate with p53 in regulation of oxidative and oncogenic stress responses. This notion is supported as follows: (a) the hypersensitive response to oxidative stress in tissues in vivo and cells in vitro derived from Fanca À/À mice is correlated with a persistent overactivation of the tumor suppressor p53; (ii) the loss of Fanca function causes prolonged oxidative DNA damage response through up-regulation of the p53 pathway; and (c) the functional status of p53 dictates the kinetics and persistence of response to oxidative and oncogenic stresses in these FA cells.
The mechanistic link between p53 signaling and FA has not been well defined. The involvement of p53 in FA pathophysiology has been highlighted by recent studies that show accelerated tumor development in Fancd1, Fancd2, or Fancc mice, also deficient for the Trp53 gene (34) (35) (36) . Furthermore, developmental defects and increased apoptosis in Fancd2-deficient zebrafish could be corrected by p53 knockdown, suggesting that p53-dependent apoptosis may be an underlying mechanism for the developmental .
defect in the Fancd2
À/À fish (38 (Fig. 5) . Thus, a functional p53 seems to be required for the survival of the mutant cells under oxidative stress. Circumstantial evidence indicates that the selectivity of p53 to regulate the prosurvival or proapoptotic signaling is affected by the growth environment, the type of stress used, the cellular context, and differential expression of the target genes (48, 49) . In response to stress, p53 induces cell growth arrest, thus preventing the damaged cells from further replication (45, 50) . More importantly, p53 can activate cell cycle checkpoint in cells with damaged DNA, which allows cells to repair the damage before reentering cell cycle. Indeed, it has been reported that p53-null cells are more sensitive to mitotic catastrophe induced by genotoxic drug (51, 52 (Fig. 6 ). This suggests that a functional Fanca may be required for the cell to engage p53 during constitutive ras activation. In contrast to oxidative DNA damage, which triggers p53 activation only transiently, activated Ras elicits persistent p53-activating signals in WT cells. Furthermore, our results show that the Fanca function is required to maintain p53 response to Ras-induced growth arrest, as restoration of p53 function after 12 days of constitutive ras activation failed to suppress proliferation of cells deficient in Fanca.
In conclusion, our results derived from both in vivo and in vitro studies using the restorable p53 model shed new light on the potential interplay between p53 and the FA pathway during cellular response to oxidative and oncogenic stresses. Our studies also define the important kinetic difference between WT and FA cells during prolonged response to oxidative DNA damage and activated oncogene signals. Additional studies into functional interaction between the p53 and FA pathways in DNA damage and oncogenic stress response may aid us in better understanding on how cells can bypass the normal checkpoints and continue to proliferate in the presence of damaged DNA and oncogenic activation. In the context of FA, new insights on the role of the FA proteins in oxidative DNA damage response/repair and oncogene activation can suggest new pathways and proteins to target for therapeutic prevention of cancer progression of the disease.
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